Skip to main content

Table 1 Patient characteristics (cohort II and CD*)

From: Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56dim natural killer cells

Characteristic

Value

Patients with GPA, n

22

Men/women, n

14/8

GPA in remission, n (%)

12/22 (55Ā %)

ā€ƒAge in years, median (range)

55.5 (35–79)

ā€ƒDuration of remission in years ā€ƒ(of inactive GPA), mean (range)

4.4 (1–20)

GPA non remission (active), n (%)

10/22 (45Ā %)

ā€ƒAge in years, median (range)

51.5 (33–64)

ā€ƒBVAS, mean (range)

4.5 (0–19)

Localized GPA (upper airways and ENT organs only), n (%)

4/22 (18Ā %)

Generalized GPA, n (%)

18/22 (82Ā %)

ANCA

Ā 

ā€ƒPositive

17/22 (77Ā %)

ā€ƒNegative

3/22 (14Ā %)

ā€ƒNot determinable

2/28 (9Ā %)

Patients with CD, n

12

Men/women, n

3/9

  1. GPA granulomatosis with polyangiitis, BVAS Birmingham vasculitis activity score, ENT ear, nose and throat, ANCA antineutrophil cytoplasmic antibody, CD* inactive systemic inflammatory control diseases other than GPA comprising systemic lupus erythematosus (n = 4), panarteriitis nodosa (n = 1), overlap connective tissue disease (n = 1), chronic inflammatory bowel disease (n = 1), CREST syndrome (n = 1), primary Sjƶgren’s syndrome (n = 1), polymyalgia rheumatica (n = 1) and giant cell arteriitis (n = 2)